Viral RNA export

Chemistry and Biology

Volumn 4, Issue 5, 1997, Pages 335-344

  Hope, Thomas J ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031148870     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(97)90124-1     Document Type: Review

References (82)

1. Dargemont, C. & Kühn, L.C. (1992). Export of mRNA from microinjected nuclei of Xenopus laevis oocytes J. Cell. Biol. 118, 1-9.
2. Jarmolowski, A., Boelens, W.C., Izaurralde, E. & Mattaj, I.W. (1994). Nuclear export of different classes of RNA is mediated by specific factors. J. Cell. Biol. 124, 627-635.
3. Zasloff, M. (1983). tRNA transport from the nucleus in a eukaryotic cell: carrier-mediated translocation process. Proc. Natl Acad. Sci. USA 80, 6436-6440.
4. Legrain, P. & Rosbash, M. (1989). Some cis- and trans-acting mutants for splicing target pre-mRNA to the cytoplasm. Cell 57, 573-583.
5. Gruss, P., Lai, C.J., Dhar, R. & Khoury, G. (1979). Splicing as a requirement for biogenesis of functional 16S mRNA of simian virus 40. Proc. Natl Acad. Sci. USA 76, 4317-4321.
6. Hamer, D.H. & Leder, P. (1979). Splicing and the formation of stable RNA. Cell 18, 1299-1302.
7. Buchman, A.R. & Berg, P. (1988). Comparison of intron-dependent and intron-independent gene expression. Mol. Cell. Biol. 8, 4395-4405.
8. Chung, S. & Perry, R.P. (1989). Importance of introns for expression of mouse ribosomal protein gene rpL32. Mol. Cell. Biol. 9, 2075-2082.
9. Neuberger, M.S. & Williams, G.T. (1988). The intron requirement for immunoglobulin gene expression is dependent upon the promoter. Nucleic Acids Res. 16, 6713-6724.
10. Malim, M.H., Hauber, J., Le, S.Y, Maizel, J.V. & Cullen, B.R. (1989). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257.
11. Malim, M.H., Bohnlein, S., Hauber, J. & Cullen, B.R. (1989). Functional dissection of the HIV-1 Rev trans-activator - derivation of a transdominant repressor of Rev function. Cell 58, 205-214.
12. Pomerantz, R.J., Seshamma, T. & Trono, D. (1992). Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency. J. Virol. 66, 1809-1813.
13. Malim, M.H. & Cullen, B.R. (1991). HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 65, 241-248.
14. Ernst, R.K., Bray, M., Rekosh, D. & Hammarskjold, M.L. (1997). A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol. Cell. Biol. 17, 135-144.
15. Bray, M., et al., & Hammarskjold, M.L. (1994). A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl Acad. Sci. USA 91, 1256-1260.
16. Ogert, R.A., Lee, L.H. & Beemon, K.L. (1996). Avian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasm. J. Virol. 70, 3834-3843.
17. Ernst, R.K., Bray, M., Rekosh, D. & Hammarskjold, M.L. (1997). Secondary structure and mutational analysis of the Mason-Pfizer monkey virus RNA constitutive transport element. RNA 3, 210-222.
18. Tabernero, C., Zolotukhin, A.S., Valentin, A., Pavlakis, G.N. & Felber, B.K. (1996). The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J. Virol. 70, 5998-6011.
19. Tabernero, C., Zolotukhin, A.S., Bear, J., Schneider, R., Karsenty, G. & Felber, B.K. (1997). Identification of an RNA sequence within an intracisternal-A particle element able to replace Rev-mediated posttranscriptional regulation of human immunodeficiency virus type 1. J. Virol. 71, 95-101.
20. Tang, H., Gaietta, G.M., Fischer, W.H., Ellisman, M.H. & Wong-Staal, F. (1997). A Cellular Cofactor for the Constitutive Transport Element of Type D Retroviruses. Science (in press).
21. Liang, L., Diehl, J.W. & Lasko, P. (1994). Localization of vasa protein to the Drosophila pole plasm is independent of its RNA-binding and helicase activities. Development 120, 1201-1211.
22. Tan, W., Felber, B.K., Zolotukhin, A.S., Pavlakis, G.N. & Schwartz, S. (1995). Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J. Virol. 69, 5607-5620.
23. Vannice, J.L. & Levinson, A.D. (1988). Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J. Virol. 62, 1305-1313.
24. Huang, J. & Liang, T.J. (1993). A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol. Cell. Biol. 13, 7476-7486.
25. Huang, Z.M. & Yen, T.S. (1994). Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm. J. Virol. 68, 3193-3199.
26. Donello, J.E., Beeche, A.A., Smith, G.J. III., Lucero, G.R. & Hope, T.J. (1996). The hepatitis B virus posttranscriptional regulatory element is composed of two subelements. J. Virol. 70, 4345-4351.
27. Huang, Z.M., Zang, W.Q. & Yen, T.S. (1996). Cellular proteins that bind to the hepatitis B virus posttranscriptional regulatory element. Virology 217, 573-581.
28. Huang, Z.M. & Yen, T.S. (1995). Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol. Cell. Biol. 15, 3864-3869.
29. Sarvetnick, N., Liggitt, D., Pitts, S.L., Hansen, S.E. & Stewart, T.A. (1988). Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class Il MHC and interferon-gamma. Cell 52, 773-782.
30. Greenspan, D.S. & Weissman, S.M. (1985). Synthesis of predominantly unspliced cytoplasmic RNAs by chimeric herpes simplex virus type 1 thymidine kinase-human beta-globin genes. Mol. Cell. Biol. 5, 1894-1900.
31. Liu, X. & Mertz, J.E. (1995). HnRNP L binds a cis-acting RNA sequence element that enables intron-dependent gene expression. Genes Dev. 9, 1766-1780.
32. Hope, T.J., Bond, B.L, McDonald, D., Klein, N.P. & Parslow, T.G. (1991). Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J. Virol. 65, 6001-6007.
33. Chang, D.D. & Sharp, P.A. (1989). Regulation by HIV Rev depends upon recognition of splice sites. Cell 59, 789-795.
34. Fischer, U., Meyer, S., Teufel, M., Heckel, C., Luhrmann, R. & Rautmann, G. (1994). Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13, 4105-4112.
35. Fischer, U., Huber, J., Boelens, W.C., Mattaj, I.W. & Luhrmann, R. (1995). The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82, 475-483.
36. Wen, W., Meinkoth, J.L., Tsien, R.Y. & Taylor, S.S. (1995). Identification of a signal for rapid export of proteins from the nucleus. Cell 82, 463-473.
37. Dabauvalle, M.C., Schulz, B., Scheer, U. & Peters, R. (1988). Inhibition of nuclear accumulation of karyophilic proteins in living cells by microinjection of the lectin wheat germ agglutinin. Exp. Cell. Res. 174, 291-296.
38. Kim, F.J., Beeche, A.A., Hunter, J.J., Chin, D.J. & Hope, T.J. (1996). Characterization of the nuclear export signal of human T-cell lymphotropic virus type 1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions. Mol. Cell. Biol. 16, 5147-5155.
39. Meyer, B.E. & Malim, M.H. (1994). The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 8, 1538-1547.
40. Pinol, R.S. & Dreyfuss, G. (1992). Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 355, 730-732.
41. Felber, B.K., Drysdale, C.M. & Pavlakis, G.N. (1990). Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein. J. Virol. 64, 3734-3741.
42. Fridell, R.A., et al., & Cullen, B.R. (1996). Amphibian transcription factor IIIA proteins contain a sequence element functionally equivalent to the nuclear export signal of human immunodeficiency virus type 1 Rev. Proc. Natl Acad. Sci. USA 93, 2936-2940.
43. Eberhart, D.E., Malter, H.E., Feng, Y. & Warren, S.T. (1996). The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5, 1083-1091.
44. Fridell, R.A., Benson, R.E., Hua, J., Bogerd, H.P. & Cullen, B.R. (1996). A nuclear role for the Fragile X mental retardation protein. EMBO J. 15, 5408-5414.
45. Murphy, R. & Wente, S.R. (1996). An RNA-export mediator with an essential nuclear export signal. Nature 383, 357-360.
46. Fridell, R.A., Bogerd, H.P. & Cullen, B.R. (1996). Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc. Natl Acad. Sci. USA 93, 4421-4424.
47. Richards, S.A., Lounsbury, K.M., Carey, K.L. & Macara, I.G. (1996). A nuclear export signal is essential for the cytosolic localization of the Ran binding protein, RanBP1. J. Cell. Biol. 134, 1157-1168.
48. Fukuda, M., Gotoh, I., Gotoh, Y.& Nishida, E. (1996). Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J. Biol. Chem. 271, 20024-20028.
49. Fritz, C.C. & Green, M.R. (1996). HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAs. Curr. Biol. 6, 848-854.
50. Bogerd, H.P., Fridell, R.A., Benson, R.E., Hua, J. & Cullen, B.R. (1996). Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. Mol. Cell. Biol. 16, 4207-4214.
51. Mancuso, V.A., Hope, T.J., Zhu, L., Derse, D., Phillips, T. & Parslow, T.G. (1994). Posttranscriptional effector domains in the Rev proteins of feline immunodeficiency virus and equine infectious anemia virus. J. Virol. 68, 1998-2001.
52. Fridell, R.A., Partin, K.M., Carpenter, S. & Cullen, B.R. (1993). Identification of the activation domain of equine infectious anemia virus rev. J. Virol. 67, 7317-7323.
53. Meyer, B.E., Meinkoth, J.L. & Malim, M.H. (1996). Nuclear transport of human immunodeficiency virus type 1, visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. J. Virol. 70, 2350-2359.
54. Fritz, C.C., Zapp, M.L. & Green, M.R. (1995). A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376, 530-533.
55. Bogerd, HP., Fridell, R.A., Madore, S. & Cullen, B.R. (1995). Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82, 485-494.
56. Stutz, F., Neville, M. & Rosbash, M. (1995). Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell 82, 495-506.
57. Stutz, F., Izaurralde, E., Mattaj, I.W. & Rosbash, M. (1996). A role for nucleoporin FG repeat domains in export of human immunodeficiency virus type 1 Rev protein and RNA from the nucleus. Mol. Cell. Biol. 16, 7144-7150.
58. Steinkasserer, A., Jones, T., Sheer, D., Koettnitz, K., Hauber, J. & Bevec, D. (1995). The eukaryotic cofactor for the human immunodeficiency virus type 1 (HIV-1) rev protein, eIF-5A, maps to chromosome 17p12-p13: three eIF-5A pseudogenes map to 10q23.3, 17q25, and 19q13.2. Genomics 25, 749-752.
59. Bevec, D., et al., & Hauber, J. (1996). Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 271, 1858-1860.
60. McDonald, D., Hope, T.J. & Parslow, T.G. (1992). Posttranscriptional regulation by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex proteins through a heterologous RNA binding site. J. Virol. 66, 7232-7238.
61. Venkatesan, S., Gerstberger, S.M., Park, H., Holland, S.M. & Nam, Y. (1992). Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA. J. Virol. 66, 7469-7480.
62. Zapp, M.L., Hope, T.J., Parslow, T.G. & Green, M.R. (1991). Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc. Natl Acad. Sci. USA 88, 7734-7738.
63. Kjems, J., Calnan, B.J., Frankel, A.D. & Sharp, P.A. (1992). Specific binding of a basic peptide from HIV-1 Rev. EMBO J. 11, 1119-1129.
64. Cochrane, A.W., Perkins, A. & Rosen, C.A. (1990). Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. J. Virol. 64, 881-885.
65. Hope, T.J., Huang, X.J., McDonald, D. & Parslow, T.G. (1990). Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc. Natl Acad Sci. USA 87, 7787-7791.
66. Daly, T.J., Rusche, J.R., Maione, T.E. & Frankel, A.D. (1990). Circular dichroism studies of the HIV-1 Rev protein and its specific RNA binding site. Biochemistry 29, 9791-9795.
67. Daly, T.J., Cook, K.S., Gray, G.S., Maione, T.E. & Rusche, J.R. (1989). Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature 342, 816-819.
68. Huang, X.J., Hope, T.J., Bond, B.L., McDonald, D., Grahl, K. & Parslow, T.G. (1991). Minimal Rev-response element for type 1 human immunodeficiency virus. J. Virol. 65, 2131-2134.
69. Daly, T.J., et al., & Rusche, J.R. (1993). Biochemical characterization of binding of multiple HIV-1 Rev monomeric proteins to the Rev responsive element. Biochemistry 32, 10497-10505.
70. Kjems, J., Brown, M., Chang, D.D. & Sharp, P.A. (1991). Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc. Natl Acad. Sci. USA 88, 683-687.
71. Hope, T.J., Klein, N.P., Elder, M.E. & Parslow, T.G. (1992). Transdominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes. J. Virol, 66, 1849-1855.
72. Bartel, D.P., Zapp, M.L, Green, M.R. & Szostak, J.W. (1991). HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67, 529-536.
73. Battiste, J.L., et al, & Williamson, J.R. (1996). Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex. Science 273, 1547-1551.
74. Ye, X., Gorin, A., Ellington, A.D. & Patel, D.J. (1996). Deep penetration of an alpha-helix into a widened RNA major groove in the HIV-1 rev peptide-RNA aptamer complex. Nat. Struct. Biol. 3, 1026-1033.
75. Jain, C. & Belasco, J.G. (1996). A structural model for the HIV-1 Rev-RRE complex deduced from altered-specificity rev variants isolated by a rapid genetic strategy. Cell 87, 115-125.
76. Lee, T.C., Sullenger, B.A., Gallardo, H.F., Ungers, G.E. & Gilboa, E. (1992). Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol. 4, 66-74.
77. Malim, M.H., et al., & Nabel, G.J. (1992). Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J. Exp. Med. 176, 1197-1201.
78. Junker, U., et al., & Bohnlein, E. (1996). Intracellular expression of cellular eif-5a mutants inhibits HIV-1 replication in human T cells: a feasibility study. Hum. Gene. Ther. 7, 1861-1869.
79. Duan, L., Bagasra, O., Laughlin, M.A., Oakes, J.W. & Pomerantz, R.J. (1994). Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc. Natl Acad. Sci. USA 91, 5075-5079.
80. Chin, D.J. (1992). Inhibition of human immunodeficiency virus type 1 Rev-Rev-response element complex formation by complementary oligonucleotides. J. Virol. 66, 600-607.
81. Li, G., et al., & Klotman, M.E. (1993). Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element. J. Virol. 67, 6882-6888.
82. Zapp, M.L., Stern, S. & Green, M.R. (1993). Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 74, 969-978.